This post was republished with permission from Zero Hedge
President Donald Trump signed an executive order Thursday expanding access to cannabis, a long-anticipated move that represents one of the most significant shifts in U.S. drug policy in decades.
“Today, I’m pleased to announce that I will be signing an executive order to reschedule marijuana from a Schedule 1 to a Schedule 3 controlled substance with legitimate medical uses,” Trump said.
He noted, “We have people begging for me to do this. People are in great pain. This action has been requested by American patients suffering from extreme pain, incurable diseases, aggressive cancers, seizure disorders, neurological problems, and more – including numerous veterans with service-related injuries and older Americans who live with chronic medical problems that severely degrade their quality of life.”
Cancer doctor: I never really thought this day would come… its really, really, really difficult to do high quality trials on a substance that's federally illegal. This rescheduling has the potential to change all of that. https://t.co/gYQtyaWvgd pic.twitter.com/ERPf4F7X4h
— Rapid Response 47 (@RapidResponse47) December 18, 2025
Last week, Tilray Brands, Canopy Growth, Aurora Cannabis, SNDL, and Cronos Group jumped on news that Trump was considering reclassifying marijuana from Schedule I to Schedule III.
* * *
Your support is crucial in helping us defeat mass censorship. Please consider donating via Locals or check out our unique merch. Follow us on X @ModernityNews.
More news on our radar
So does this open the use of banks to businesses in the MJ game, in legal states?